Shh Pathway Activity is Down-regulated in Cultured Medulloblastoma Cells: Implications for Preclinical Studies.
From: Department of Developmental Neurobiology, Saint Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
Cancer research
- Publish Date: Apr 2006
- ISSN: 0008-5472
- Volume: 66
- Issue: 8
- Pages: 4215-22
- Medium: Print
- Language: English
- Citation (JAMA): Sasai Ken, Romer Justyna T, Lee Youngsoo, et al. Shh Pathway Activity is Down-regulated in Cultured Medulloblastoma Cells: Implications for Preclinical Studies.. Cancer Res. Apr 2006;66:4215-22
Abstract
Gene expression profiling indicates that the Sonic Hedgehog (Shh) pathway is active in approximately 30% of human medulloblastomas, suggesting that it could provide a useful therapeutic target. Previously, we showed that spontaneous medulloblastomas in Ptc1(+/-)p53-/- mice could be eradicated by treatment with a small-molecule inhibitor (HhAntag) of Smoothened (Smo). Here, we compared the responses of mouse medulloblastoma cells propagated in flank allografts, either directly or after culture in vitro, to HhAntag. We found that Shh pathway activity was suppressed in medulloblastoma cells cultured in vitro and it was not restored when these cells were transplanted into the flank of nude mice. The growth of these transplanted tumor cells was not inhibited by treatment of mice with doses of HhAntag that completely suppressed Smo activity. Interestingly, tumor cells transplanted directly into the flank maintained Smo activity and were sensitive to treatment with HhAntag. These findings indicate that propagation of tumor cells in culture inhibits Smo activity in a way that cannot be reversed by transplantation in vivo, and they raise concerns about the use of cultured tumor cells to test the efficacy of Shh pathway inhibitors as anticancer therapies.
Mesh Headings (Keywords): Animals, Cell Line, Tumor, Down-Regulation, Female, Gene Expression Profiling, Hedgehog Proteins, Medulloblastoma, Mice, Mice, Nude, Neoplasm Transplantation, Receptors, Cell Surface, Receptors, G-Protein-Coupled, Trans-Activators, Tumor Suppressor Protein p53
Check for Full Text / PubMed Unique Identifier (PMID): 16618744
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.